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ABSTRACT
THE SELF-EFFICACY OF BIOLOGICAL MOTHERS AND FOSTER MOTHERS
CARING FOR INFANTS PRENATALLY EXPOSED TO DRUGS OR TREATED FOR
NAS: EXAMINATION OF POTENTIALLY INFLUENCING FACTORS
Megan K. Sherehiy
April 22, 2019
This study sought to identify demographic risk and protective factors that may
relate to parental self-efficacy in biological and foster mothers caring for infants
prenatally exposed to opioids. The study also examined whether participation in
treatment for biological mothers and in training for foster mothers was associated with
parental self-efficacy. Forty-nine women (21 biological mothers and 28 foster mothers)
were surveyed. Measures included demographic, treatment, and training information. A
single-item, self-report measure was used to assess satisfaction with support from friends
using an item from the World Health Organization Quality of Life-Bref scale
(Skevington, Lotfy, & O'Connell, 2004). The Karitane Parenting Confidence Scale was
used to measure mothers’ parental self-efficacy (Črnčec, Barnett, & Matthey, 2008).
Results found significant differences in demographic representation between biological
and foster mothers, but did not find a significant association between parental selfefficacy and participation in treatment for biological mothers or in training for foster
mothers.
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CHAPTER 1
INTRODUCTION
Background
Neonatal Abstinence Syndrome (NAS)
Neonatal abstinence syndrome (NAS) is a clinical diagnosis resulting from the
discontinuation of fetal exposure to opioids (Hudak et al., 2012; Kocherlakota, 2014).
NAS was first described in the 1970s, and more recently the designation of neonatal
opioid withdrawal syndrome (NOWS) has been made to denote a specific classification
of NAS estimated to affect 50 to 80% of infants exposed to opioids in utero (Kakko,
Heilig, & Sarman, 2008; Reddy Uma, Davis, Ren, & Greene, 2017; Sutter, Leeman, &
Hsi, 2014).
While NAS is a general term used widely in existing literature, NOWS is being
used to more accurately identify infants experiencing withdrawal from prenatal exposure
to opioids; this distinction is clinically relevant because the assessment and treatment of
these infants may differ compared to infants exposed to other substances (Klaman et al.,
2017). Since NAS occurs in 55 to 94% of newborns whose mothers used or were treated
with opioids while pregnant, not all infants prenatally exposed to opioids will be
diagnosed (McQueen & Murphy-Oikonen, 2016). Regardless, the current study sought to
examine the impact of treatment programs for women who used opioids while pregnant
in optimizing parental self-efficacy (PSE) and child outcomes in these high-risk
populations, so it was inclusive of women who used a variety of drugs while pregnant in
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addition to foster mothers caring for infants who were diagnosed with NOWS, NAS, or
exposed but not diagnosed. The general term, NAS, is used here to reflect this broad
inclusivity.
Clinical signs of NAS usually present within the first few days of birth and vary
in onset, type, and severity (McQueen & Murphy-Oikonen, 2016). Common signs
include irritability, tremors, excessive crying, and diarrhea, with seizures sometimes
occurring in more severe cases (Kocherlakota, 2014). As a result, newborns with NAS
tend to be more agitated, have trouble sleeping, and experience difficulties feeding
(Maguire, Rowe, Spring, & Elliott, 2015). The mild to severe illness associated with NAS
often leads to prolonged hospital stays for the newborn (Kocherlakota, 2014).
According to the Centers for Disease Control and Prevention, the overall
incidence of NAS increased 300% from 1.5 per 1,000 hospital births in 1999 to six per
1,000 hospital births in 2013 (Ko et al., 2016). In Kentucky, the rise was even more
dramatic, climbing from .4 per 1,000 hospital births in 2000 to 15 per 1,000 hospital
births in 2013 (Ko et al., 2016). This increase corresponds with the recent rise in opioid
use during pregnancy, which has been linked to many contributing factors, including the
higher use of prescribed opioids for pain control in pregnant women (McQueen &
Murphy-Oikonen, 2016).
Management of NAS involves nonpharmacological treatment methods such as
gentle handling, on-demand feeding, swaddling, dim lighting, low noise, kangaroo care,
and rooming-in of mother and infant (Kocherlakota, 2014). While preliminary studies
have demonstrated benefits of these methods, additional large-scale, randomized
controlled studies are needed to determine its effectiveness and establish standardized
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guidelines (McQueen & Murphy-Oikonen, 2016). Since 60 to 80% of infants do not
respond to nonpharmacological treatment, pharmacological treatment of symptoms with
morphine, methadone, or buprenorphine is also an essential component in NAS
management (Kocherlakota, 2014; McQueen & Murphy-Oikonen, 2016). Despite its
widespread use, no universal standard of care exists for pharmacological treatment
(McQueen & Murphy-Oikonen, 2016). Typically, clinicians use scoring systems, such as
the Finnegan scoring system, to monitor and assess the severity of NAS, which can help
determine when pharmacological treatment is needed and assist in monitoring, adjusting
and ending therapy (Finnegan, Connaughton, Kron, & Emich, 1975; Kocherlakota,
2014).
Treatment for Mothers with Substance Use Disorders
Efforts are being made, through formal programs and interventions, to assist
women with modifying their behavior and thereby positively influencing the infant
(Shaw et al., 2015). The mother’s participation in caring for her infant is potentially
beneficial to both as she can learn about the neurobehavioral difficulties the infant may
have and the special attention that will be required (Boukydis & Lester, 2008). This
awareness and ability to actively participate in the infant’s care can enhance mother and
infant interaction and bonding (Boukydis & Lester, 2008).
There is no standardized treatment program for pregnant women with substance
use disorders (SUD), but the World Health Organization (WHO) recommends that care
adheres to the following principles: prioritizing prevention, ensuring access to prevention
and treatment, respecting patient autonomy, providing comprehensive care, and
safeguarding against discrimination and stigmatization (World Health Organization
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guidelines for the identification and management of substance use and substance use
disorders in pregnancy, 2014).
Pharmaceutical management for pregnant women with SUD includes medication
assisted withdrawal (MAW) or medication assisted treatment (MAT) (Klaman et al.,
2017). MAW has been found to pose a risk of relapse before delivery and is associated
with poor prenatal outcomes (Kahn et al., 2017; Klaman et al., 2017). The American
College of Obstetricians and Gynecologists recommends MAT with methadone or
buprenorphine during pregnancy for women using opioids ("ACOG statement on opioid
use during pregnancy," 2016). While methadone is more common, recent studies have
found that buprenorphine might reduce the amount of morphine needed to treat newborns
with NAS, reduce their length of hospital stay, lower risk of preterm birth, and contribute
to greater birth weight and larger head circumference when compared with methadone
treatment (Fischer et al., 2000; H. E. Jones et al., 2011; Kahn et al., 2017; Klaman et al.,
2017).
Practitioners are also testing comprehensive treatment programs in outpatient and
residential settings for pregnant women with SUD (Haug, Duffy, & McCaul, 2014).
These programs may include MAT as well as prenatal and psychosocial care combined
with education on pregnancy, delivery, postpartum care, and parenting (Buckley,
Razaghi, & Haber, 2013; Haug et al., 2014; Kahn et al., 2017). Two models include
relationship-focused intervention (RFI) and standard integrated treatment (SIT), both of
which combine parenting support with addiction services for mothers who are pregnant
or parenting young children (Espinet, Motz, Jeong, Pepler, & Jenkins, 2016). In a
comparison of these models, Espinet et al. (2016) found that a higher number of women
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who participated in RFI achieved addiction self-efficacy and that mothers with mental
health issues saw reduced symptoms of depression and anxiety. In a review of programs
that included relational aspects, Kramlich and Kronk (2015) found that early qualitative
data indicates positive outcomes, such as mothers developing relationships with members
of multidisciplinary teams essential for their healing and engagement in care.
Despite the demonstrated benefit of these programs, many women with SUD
encounter barriers to accessing resources, treatment programs, prenatal care, and
parenting support (Fraser, Barnes, Biggs, & Kain, 2007; Kramlich & Kronk, 2015).
These barriers can be particularly acute for pregnant women in rural areas, such as
Appalachian Kentucky, where Brown, Goodin, and Talbert (2018) found higher relative
rates of NAS along with a relative lack of access to treatment. Other barriers that this
population might encounter include the stigmatization, and in some cases criminalization,
of substance use, which can make women reluctant to seek treatment and prenatal care
(Kramlich & Kronk, 2015; Lester, Andreozzi, & Appiah, 2004).
Training for Foster Families Caring for Infants Exposed to Opioids
With evidence showing that infants prenatally exposed to substances are more
likely to be placed in foster care within months from birth, awareness of the need to
support foster families who care for these infants and children is also growing (Eiden,
Foote, & Schuetze, 2007). Children in foster care are at increased risk for behavioral and
emotional problems, requiring additional training on parenting skills that may help
manage or reduce adverse outcomes (Solomon, Niec, & Schoonover, 2017).
Despite the clear need, there is a shortage of standardized programs and limited
evidence on how to develop evidence-based programs that educate and support foster
parents caring for infants prenatally exposed to substances (D'Angiulli & Sullivan, 2010;
5

Marcellus, Shaw, MacKinnon, & Gordon, 2017). However, programs are being
developed, such as in Kentucky, where the Department of Community Based Services
(DCBS) offers training in the topic area of “the effect of substance use, abuse, or
dependency by either the child or the child’s biological parent” as an additional training
not required for Basic level foster home approval (Cabinet for Health and Family
Services Online Standards of Practice Manual, 2018).
Both kinship and non-relative foster parents offer a familial environment that
contributes to ensuring the safety, stability, and well-being of children and youth (Lietz,
Julien-Chinn, Geiger, & Piel, 2016). Though fathers may also provide foster care, the
mother typically takes more responsibility for daily child care and communication with
the birth family (Wilson, Fyson, & Newstone, 2007). Day-to-day caretaking of an infant
who may have been affected by intrauterine exposure or treated for NAS can include loss
of sleep, coordination of the baby’s health care and therapies as needed, provision of
adequate nutrition, and service as an interpreter for the infant’s behavioral cues
(Marcellus et al., 2017).
Current research indicates that early foster care may provide a supportive
environment for positive developmental outcomes as it can potentially counteract early
deficits associated with prenatal exposure (D'Angiulli & Sullivan, 2010). When
supported with training and resources that promote resiliency, which can influence selfefficacy, foster families can provide a protective caregiving environment in which infants
at risk may overcome or compensate for early stressors (Marcellus, 2010).
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Problem Statement
Developmental Outcomes Related to NAS
In addition to its immediate clinical signs, NAS is also associated with early
cognitive and motor delays, as prenatal exposure to drugs can impact fetal development
of brain structures and function (Ko et al., 2016; Logan, Brown, & Hayes, 2013; Ross,
Graham, Money, & Stanwood, 2015). There are a variety of mechanisms related to
intrauterine exposure that can potentially have consequences long after birth, including
drugs that cross the placenta acting on the fetus directly, affecting the placenta or uterus,
and indirectly resulting in harm due to destructive maternal behavior related to addiction
(Ross et al., 2015). Though all prenatal drug use can negatively impact a fetus, factors
such as the type of drug or drugs used, the amount, and the most recent use can influence
symptoms presented after birth (Ross et al., 2015).
Studies focusing on infancy and early childhood have found that infants born to
mothers who used opioids or polysubstances during pregnancy had lower cognitive
performance and affect regulation, as well as smaller neuroanatomical volumes and lesser
maturation of neural tracts than non-exposed infants (Nygaard, Moe, Slinning, &
Walhovd, 2015). Children with a diagnosis of NAS have also been found to be at
increased risk of being rehospitalized due to visual disorders, mental health issues, and
behavioral problems (Uebel et al., 2015). However, according to Nygaard et al. (2015)
few studies to date have followed children exposed to opioids in utero past their first
years of life to determine specific long-term implications.
Complicating matters, the confounding issues of polysubstance use and cooccurring environmental and medical risk factors may interact with prenatal exposure,
leading to epigenetic changes that can have immediate and long-term implications on
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development (Lester et al., 2011). For example, children prenatally exposed to opioids
may exhibit decreased long-term cognitive functioning, but exposure to polysubstances
makes isolating causality challenging (Nygaard et al., 2015). Environmental risk factors
include low socioeconomic status, nonoptimal postnatal environment, and lower maternal
education and employment, while medical risk factors include poor prenatal care, low
birth weight, and severity and treatment for NAS (Konijnenberg & Melinder, 2015;
Logan et al., 2013; Nygaard et al., 2015). In addition, children of mothers using illicit
substances are at a higher risk for poor outcomes due to on average lower levels of
maternal sensitivity among populations at heightened risk for poor child outcomes due to
the environmental risk factors previously mentioned and residing in areas associated with
financial disadvantage (Hatzis, Dawe, Harnett, & Barlow, 2017).
Early Experience & Environmental Impact on Development
While long-term developmental outcomes for infants exposed to opioids in utero
are unclear, there is evidence supporting the influence of early experiences and
environment on the developing brain, and in turn on the progression of overall
development (Fox, Levitt, & Nelson, 2010; Inguaggiato, Sgandurra, & Cioni, 2017;
Tierney & Nelson, 2009). Specifically, parent-child interaction, nutrition, and
neuroendocrine signals have been identified as significant experiential and environmental
factors that influence the maturation of neural circuits and play a role in physical and
mental changes (Inguaggiato et al., 2017). These changes reflect the neuroplasticity that
exists as a result of complex processes and interactions that occur throughout life
(Knudsen, 2004). Though changes take place across the life span, there are vital
windows, or sensitive periods, in which experiences either potentiate or inhibit neural
connections; and when neural connections necessary for normal development are
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established and result in permanent changes, sensitive periods are termed critical periods
(Knudsen, 2004).
Early experience and environment influence speech, language, and cognitive
development (Tierney & Nelson, 2009). Play emerges through experience, allowing a
child to interact with his or her environment in ways that encourage the emergence of
advanced skills and competencies (Blasi & Hurwitz, 2002). Feeding and nutritional
intake are also influenced, both physiologically and relationally, by early experiences
(Harbron & Booley, 2013; Shloim, Edelson, Martin, & Hetherington, 2015; Worobey,
Lopez, & Hoffman, 2009).
While healthy experiences support neural development, the lack of positive
experiences or experiencing toxic stress prenatally or in early childhood during sensitive
periods can be detrimental (Shonkoff & Garner, 2012). Adverse childhood experiences
(ACEs) can produce this toxic stress response, which has the potential to lead to impaired
language, attention, and social-emotional skills, such as social communication and
impulse control (Anda et al., 2006; Henry, Sloane, & Black-Pond, 2007; Shonkoff &
Garner, 2012). However, neuroplasticity allows for improvement of cognitive function
and self-regulation impaired by early life experiences (McEwen & Morrison, 2013).
As a means of discovering the influence of early experiences on development,
researchers from three major institutions created the Bucharest Early Intervention Project
(BEIP) to examine the effects of institutionalization on infants and young children
(Marshall, Fox, & The Bucharest Early Intervention Project Core, 2004). Although
institutions vary, many are characterized by unfavorable caregiver-to-child ratios with
low levels or responsivity, strict routines, and minimal stimulation, which was true of the
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institutions included in this project due to the extraordinary number of orphaned and
abandoned children in Romania at the time (Marshall et al., 2004).
As part of the initiative, Marshall et al. (2004) examined electroencephalography
(EEG) data from a sample of infants and young children who were institutionalized and
compared it to data of age-matched peers from the local area who had never been
institutionalized and who lived with their families. The institutionalized sample showed
EEG results that were consistent with EEG studies of children who were living in adverse
environments and children with diagnosed learning disorders, reflecting a lag in central
nervous system development (Marshall et al., 2004). A follow-up study of the children in
the 2004 sample compared the children who were institutionalized to the children who
had been randomly assigned to foster care and found that the EEGs of children who were
transferred to foster care reflected positive neurophysiological changes in the central
nervous system, with these changes partly dependent on age at placement into foster care
(Marshall, Reeb, Fox, Nelson, & Zeanah, 2008).
In another study from the BEIP, Nelson et al. (2007) compared the development
of young children who were abandoned and placed in institutions to the development of
young children who were placed in institutions but later transferred to foster care, and to
age-matched peers who had never been institutionalized and who lived with their
families. All children were less than 31 months at the initiation of the study and were
assessed at intervals through the age of 54 months using the Bayley Scales of Infant
Development-II (BSID-II) (Bayley, 1993) and the Wechsler Preschool Primary Test of
Intelligence (WPPSI) (Wechsler, 1967) (Nelson et al., 2007). Children who remained
institutionalized had severely diminished intelligence scores compared to the children
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who had never been institutionalized, while the children who were initially
institutionalized but moved to foster care exhibited improvements in cognitive scores
with greater gains positively correlated to earlier placement in foster homes (Nelson et
al., 2007).
Maternal Self-Efficacy
Recognition of the role of early experiences and environment, which are inclusive
of caregiver and child interaction (Inguaggiato et al., 2017), and of critical developmental
stages (Knudsen, 2004), highlights the importance of prevention first, but also in
optimizing the care of infants who were exposed to opioids in utero. The ability to
participate in the infant’s care can enhance mother and infant interaction and bonding,
which can influence early experiences and facilitate a supportive environment (Coleman
& Karraker, 2003).
Maternal self-efficacy (MSE) is an essential construct concerning a mother’s
ability to provide appropriate care and a nurturing environment. MSE is a mother’s
dynamic belief about her ability to perform the multiple tasks associated with caring for
her child that can be influenced by both internal and external factors, and is considered to
impact actual parenting behaviors (Salo et al., 2009; Troutman, Moran, Arndt, Johnson,
& Chmielewski, 2012).
The belief in one’s parenting ability is critical as higher self-efficacy is associated
with mothers being more attentive, sensitive, and interactive, and with infants possessing
a greater capacity to signal, to interact positively, and to develop cognitively (Coleman &
Karraker, 2003). Higher PSE is related to parenting behaviors conducive to a positive
child-rearing environment, which maximizes children’s development and leads to
improved long-term outcomes, including higher self-regulation and self-worth, lower
11

levels of anxiety, improved academic performance, and fewer behavioral problems in
adolescents (Bogenschneider, Small, & Tsay, 1997; Coleman & Karraker, 2003; Hill &
Bush, 2001; Murry & Brody, 1999). In contrast, low PSE might be considered a
predictive risk factor of child maltreatment, as lacking the confidence in oneself to parent
successfully may lead to harsher parenting practices that have the potential to develop
into abuse (T. L. Jones & Prinz, 2005).
Self-efficacy can be susceptible to a variety of factors. According to the theory
posited by Bandura (1982), there are four ways to modify self-efficacy: 1) Enactive
mastery, such as gaining personal experience in certain activities, 2) Vicarious
experiences, such as observing competent models of challenging activities, 3) Verbal and
social persuasion, such as receiving verbal feedback related to performance of a specific
task, and 4) Emotional and physiological arousal, such as the experience of emotions
and/or physiological responses such as stress related to specific tasks.
Higher levels of education and household income have also been found to predict
higher overall PSE (Coleman & Karraker, 2003; Shorey, Chan, Chong, & He, 2015).
Coleman and Karraker (2003) attribute this to a broader knowledge of child development
and effective parenting strategies, as well as the ability to provide more goods,
experiences, and opportunities for their children while investing in social supports such
as babysitters to reduce stress on mothers. Other variables that may affect PSE have been
examined, such as increased demands associated with caring for medically complex
infants and children (Meirsschaut, Roeyers, & Warreyn, 2010; Porter & Hsu, 2003) and
satisfaction with marital and social support (Kersh, Hedvat, Hauser-Cram, & Warfield,
2006; Teti & Gelfand, 1991).
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This study seeks to determine those factors that best encourage favorable PSE so
that efforts can be made to ensure the necessary supports are available for families caring
for infants who were prenatally exposed to opioids.
Specific Aims
The specific aims of this study were to examine the following: 1. The
identification of potential demographic risk and protective factors that may relate to PSE
in mothers who used opioids during pregnancy; 2. The identification of potential
demographic risk and protective factors that may relate to PSE in foster mothers caring
for infants who were prenatally exposed to opioids; 3. The PSE of mothers who have
used opioids during past or current pregnancies and who have delivered infants whose
intrauterine development may have been impacted by prenatal exposure to opioids; and,
4. The PSE of foster mothers who care for infants whose intrauterine development may
have been affected by prenatal exposure to opioids.
Research Hypotheses
The research hypotheses are as follows. Note that formal treatment programs for
biological mothers include any single or combination of the following: pharmacological
treatment, outpatient treatment that included pharmacological treatment as well as
counseling and education on the effects of prenatal substance exposure, and residential
treatment that included pharmacological treatment as well as counseling and education on
the effects of prenatal substance exposure.
H1: There will be a significant difference in the demographic representation,
based on age, marital status, education, employment, and income, between biological
mothers and foster mothers.

13

H2: Biological mothers who participated in formal programs to treat their
addiction during their current pregnancy will have higher perceived parenting selfefficacy than biological mothers who participated in formal programs during a past
pregnancy.
H3: Foster mothers who received at least five hours of specialized training
relating to prenatal drug exposure or neonatal abstinence syndrome will have higher
perceived parenting self-efficacy than those who have not received specialized training.
Null Hypotheses
H01: There will not be a significant difference in the demographic representation,
based on age, marital status, education, employment, and income, between biological
mothers and foster mothers.
H02: Biological mothers who participated in formal programs to treat their
addiction during their current pregnancy will not have higher perceived parenting selfefficacy than biological mothers who participated in formal programs during a past
pregnancy.
H03: Foster mothers who received at least five hours of specialized training
relating to prenatal drug exposure or neonatal abstinence syndrome will not have higher
perceived parenting self-efficacy than those who have not received specialized training.
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CHAPTER 2
METHODS
Participants
Approval for this study was granted by the Institutional Review Boards (IRB) of
the University of Louisville (IRB # 18.0268) and Norton Healthcare Research Office
(RO). This study utilized a patient survey administered in person to biological mothers
and foster mothers at Norton Children’s Neonatology (NCN) clinic and the Center for
Behavioral Health (CBH) in Louisville, Kentucky. A total of 49 mothers participated in
the study, including 21 biological mothers and 28 foster mothers. Eligible participants
included mothers who used or were treated with opioids during pregnancy and foster
mothers who cared for infants who had been prenatally exposed to opioids. In addition,
participants also met all of the following conditions: 1. The participant’s infant received
follow up at NCN clinic or the participant was receiving treatment at the CBH; 2. The
participant was between 18 years and 50 years of age; and, 3. The participant
demonstrated sufficient understanding of informed consent and was able to read and
understand questionnaire items. Patients were excluded if they met any of the following
criteria: 1. Patients were below age 18 years of age; 2. Patients had a diagnosis of
intellectual disability; and, 3. Patients did not care for an infant who was prenatally
exposed.
Data Collection
Mothers were approached by student researchers to complete the survey at
follow-up visits at NCN or treatment sessions at the CBH. Student researchers provided
15

patients with a formal handout that included a brief explanation of the study and contact
information for the principal investigator (PI) as a resource for questions about the study.
If the patient agreed to participate, a paper or electronic copy of the survey was provided
by the student researcher. Electronic copies of the survey were set up in Qualtrics, an
online survey platform, and completed by the participant on a tablet computer. The
survey contained a preamble in which completion of the tool verified consent. Each
participant was involved in the study for the duration of the survey. Student researchers
collected surveys at NCN clinic for one to two days a week from May 18, 2018 to
October 23, 2018, and at the CBH for one day on November 6, 2018.
There were two versions of the survey; one version was for biological mothers
and one version was for foster mothers. The survey for biological mothers included selfreport treatment participation questions in which mothers indicated programs accessed
during the current pregnancy or past pregnancies. The survey for foster mothers included
a self-report training question in which mothers stated the hours of foster parent training
received in the last 12 months that was related to prenatal drug exposure. Both versions
presented self-report demographic questions, including zip code of residence, age,
number of children, number of deliveries, marital status, level of education, employment
status, racial-ethnic background, and annual household income. Foster mothers were also
asked to report number of foster children cared for in the past and number of foster
children currently in their care.
A single-item, self-report measure was developed to assess satisfaction with
support received from friends using an item from the World Health Organization Quality
of Life (WHOQOL) Bref scale (Skevington et al., 2004). Satisfaction with the support of
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friends was measured by the question: “How satisfied are you with the support you get
from your friends?” with the response scale ranging from 1 - “Very dissatisfied” to 9 “Very satisfied.” The Karitane Parenting Confidence Scale (KPCS), a validated 15-item
self-report instrument was used to measure mothers’ perceived parental self-efficacy
(PPSE) related to caring for the infant. Items on the KPCS are rated on a 4-point Likert
scale with higher scores representing increased PPSE. The KPCS provides clinical ranges
of non-clinical, mild, moderate, or severe related to the total score, with scores at 39 and
below indicative of low parenting confidence (Črnčec et al., 2008). The scale included a
preamble; thus minimal instruction was required during administration.
Data Analysis
All completed surveys were exported from Qualtrics to Excel (Microsoft) and
numerically coded in preparation for analysis. Data were exported to SPSS Version 25
(Microsoft) for statistical analysis, checked for distribution, and normalization
transformations were applied. Descriptive and summary statistics values were calculated
to describe the sample. Wilcoxon Signed-Rank Tests were conducted to assess whether
there was a significant difference in the demographic representation, based on age,
marital status, education, employment, and income, between biological mothers and
foster mothers. A Mann-Whitney U Test was conducted to assess whether an association
existed between PPSE and participation in formal treatment programs during past
pregnancies compared to participation in formal treatment programs during the current
pregnancy for biological mothers. A Mann-Whitney U Test was also conducted to assess
whether an association existed between PPSE and participation in specialized training
relating to prenatal drug exposure for foster mothers. Descriptive and summary statistics,
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as well as the results of these analyses, are provided in Chapter 3. Continuous data
expressed as mean ± standard deviation.
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CHAPTER 3
RESULTS
Descriptive and Summary Statistics
This study utilized a patient survey administered in person to women (N = 49) at
NCN clinic and the CBH. Participants included biological mothers (n = 21) and foster
mothers (n = 28). The age of participants ranged from 18 to 50 years, with 48% (n = 23)
of all participants within the age range of 26-33 years. Of all participants, 90% (n = 43)
of participants identified as Caucasian, 8% (n = 4) identified as African American, and
2% (n = 1) identified as Pacific Islander.
Biological mothers reported number of deliveries ranging from one to five or
more (2 ± 1) and number of biological children ranging from one to five or more (2 ± 1).
Foster mothers reported number of biological children ranging from zero to four (2 ± 1),
number of foster children cared for in the past ranging from zero to four (2 ± 2), and
number of foster children currently in their care ranging from one to four (2 ± 1).
During a past or current pregnancy, 86% (n = 18) of biological mothers reported
participating in at least one formal treatment. During their current pregnancy, 14% (n = 3)
participated in an outpatient program, 24% (n = 5) participated in a residential program,
5% (n = 1) participated in pharmacological and residential programs, 5% (n = 1)
participated in pharmacological, outpatient, and residential programs, and 10% (n = 2)
did not participate in any program. Nine participants (43%) did not provide an answer
regarding participation in treatment programs during current pregnancies. During a past
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pregnancy, 38% (n = 8) participated in an outpatient program, 5% (n = 1) participated in
pharmacological and residential programs, 10% (n = 2) participated in outpatient and
residential programs, and 5% (n = 1) did not participate in any program. Nine mothers
(43%) did not provide an answer regarding participation in treatment programs during
past pregnancies.
Nine foster mothers (39%) reported participating in at least five hours of
specialized foster parent training relating to prenatal drug exposure within the past 12
months. In the sample, 30% (n = 7) of mothers participated in five hours or less of
specialized foster parent training, 9% (n = 2) of mothers participated in 13-24 hours of
training, and 61% (n = 14) of mothers did not participate in training. Five mothers (18%)
did not provide an answer regarding participation in specialized training.
Regarding satisfaction with support received by friends, 14% (n = 3) of biological
mothers were very dissatisfied, 5% (n = 1) were moderately dissatisfied, and 5% (n = 1)
were slightly dissatisfied. No foster mothers indicated being very dissatisfied or
moderately dissatisfied with support received from friends, and 12% (n = 3) were slightly
dissatisfied. Nineteen percent (n = 4) of biological mothers were very satisfied with
support received from friends, 14% (n = 3) were moderately satisfied, and 33% (n = 7)
were slightly satisfied. Of the foster mothers reporting, 39% (n = 10) were very satisfied,
15% (n = 4) were moderately satisfied, and 31% (n = 8) were slightly satisfied.
Total KPCS scores for all mothers ranged from 35 to 45 (Mdn = 42), with total
scores for biological mothers ranging from 35 to 45 (Mdn = 42) and total scores for foster
mothers also ranging from 35 to 45 (Mdn = 42). Twenty percent (n = 4) of biological
mothers scored in the clinical range, with 15% (n = 3) scoring in the mild clinical range
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and 5% (n = 1) scoring in the moderate clinical range. Of the foster mothers, 18% (n = 5)
scored in the clinical range, with 14% (n = 4) scoring in the mild clinical range and 4% (n
= 1) scoring in the moderate clinical range.
See Tables 1-10 for more detail regarding descriptive and summary statistics.
Non-Parametric Analysis
Wilcoxon Signed-Rank Tests were conducted to compare demographic variables
between biological mothers and foster mothers. Tests indicated that the median test rank
for the biological mothers was statistically significantly lower than the median test rank
for the foster mothers in the areas of age (Z = -2.30, p = 0.02); marital status (Z = -3.32, p
= 0.001); education level (Z = -2.11, p = 0.04); and, household income (Z = -3.29, p =
0.001). Biological mothers ranged in age from 18-25 to 42-50 (Mdn = 26-33), and foster
mothers ranged in age from 18-25 and 42-50 (Mdn = 34-41). The median marital status
was “Never Married” for biological mothers and “Currently Married” for foster mothers.
The median educational level was “High School” for biological mothers and “Technical
School” or “Bachelor’s Degree” for foster mothers. Biological mothers reported
household incomes ranging from $0-$20,000 to $100,000 and above (Mdn = $20,000$39,999). Foster mothers reported household incomes ranging from $0-$20,000 to
$100,000 and above (Mdn = $60,000-$79,999). There was not a statistically significant
difference in employment status between the two samples of mothers (Z = -1.61, p =
0.11). See tables 11-12 for more detail.
A Mann-Whitney U Test was conducted to compare total KPCS scores of
biological mothers who participated in a formal treatment program during a past
pregnancy (n = 11) to biological mothers who participated in a formal treatment program
during their current pregnancy (n = 9). One biological mother’s score was not included in
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the test due to no responses on three KPCS items. The analysis indicated that there was
no statistically significant difference in total KPCS scores of biological mothers who had
completed formal treatment programs during a past pregnancy (Mdn = 42) compared to
biological mothers who had completed formal treatment programs during the current
pregnancy (Mdn = 41; U = 37.00, p = 0.37). See tables 13-14 for more detail.
A Mann-Whitney U Test was also conducted to compare total KPCS scores for
foster mothers who had completed at least five hours of specialized foster parent training
relating to prenatal drug exposure (n = 9) to foster mothers who had completed no
specialized training (n = 14). The test indicated that there was no statistically significant
difference in total KPCS scores of foster mothers who had received specialized training
(Mdn = 41) and foster mothers who had not received specialized training (Mdn = 43; U =
40.00, p = 0.16). See tables 15-16 for more detail.
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Table 1
Demographic Characteristics of Participants.
Biological
Mothers
n
%
3 14%
13 62%
3 14%
2 10%

Foster
Mothers
n
%
1
4%
10 37%
4 15%
12 44%

Total
Sample
N
%
4
8%
23 48%
7 15%
14 29%

Age

18-25
26-33
34-41
42-50

Marital Status

Never Married
Married
Partnered
Separated
Divorced
Widowed

12
3
3
1
2
0

57%
14%
14%
5%
10%
0%

4
19
0
1
3
1

14%
68%
0%
4%
11%
4%

16
22
3
2
5
1

33%
45%
6%
4%
10%
2%

Education

High School
Technical School
Bachelor's Degree
Master's Degree

13
4
4
0

62%
19%
19%
0%

11
3
10
4

39%
11%
36%
14%

24
7
14
4

49%
14%
29%
8%

Employment

Not working
10-20 hours
20-35 hours
36+ hours

10
1
4
6

48%
5%
19%
29%

6
2
2
18

21%
7%
7%
64%

16
3
6
24

33%
6%
12%
49%

Race

Caucasian
African American
Pacific Islander

19
1
1

91%
5%
5%

24
3
0

89%
11%
0%

43
4
1

90%
8%
2%

Income

$0-$20,000
$20,000 - $39,999
$40,000 - $59,999
$60,000 - $79,999
$80,000 - $99,999
$100,000 or more

11
7
1
0
1
1

52%
33%
5%
0%
5%
5%

5
0
4
5
7
5

19%
0%
15%
19%
27%
19%

16
7
5
5
8
6

34%
15%
11%
11%
17%
13%
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Table 2
Number of Deliveries and Biological Children (Biological Mothers).

Number of Deliveries
Number of Biological Children

M
2
2

Biological Mothers
+
SD
Min
+
1
1
+
1
1

Max
5+
5+

Table 3
Number of Biological and Foster Children (Foster Mothers).

Number of Biological Children
Number of Foster Children (Past)
Number of Foster Children (Current)

M
2
2
2

Foster Mothers
+
SD
Min
+
1
0
+
2
0
+
1
1

Table 4
Treatment Program Participation (Biological Mothers).
Biological Mothers
Treatment Program
Participation
Any Program

n
None
At Least One

3
18

24

%
14%
86%

Max
4
4
4

Table 5
Type of Treatment Program in Current vs. Past Pregnancy (Biological Mothers).
Pregnancy
Current
Pregnancy

Past
Pregnancy

Type of Program*
Valid

f

%

Valid %

Cum. %

None
Pharm, OP, Res
Pharm, Res
OP
Res
Total

9
2
1
1
3
5
21

43%
10%
5%
5%
14%
24%
100%

43%
10%
5%
5%
14%
24%
100%

43%
52%
57%
62%
76%
100%

None
Pharm, Res
OP
OP, Res
Total

9
1
1
8
2
21

43%
5%
5%
38%
10%
100%

43%
5%
5%
38%
10%
100%

43%
48%
52%
91%
100%

Valid

* Pharm = pharmaceutical program, OP = outpatient program, Res = residential program
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Table 6
Participation in Any Treatment Program (Biological Mothers).
Type of
Program*
Any
Program

Pharm

OP

Res

f

%

Valid %

Cum. %

Valid
Did Not Participate
Participated
Total

5
16
21

24%
76%
100%

24%
76%
100%

24%
100%

Did Not Participate
Participated
Total

18
3
21

86%
14%
100%

86%
14%
100%

86%
100%

Did Not Participate
Participated
Total

8
13
21

38%
62%
100%

38%
62%
100%

38%
100%

Did Not Participate
Participated
Total

11
10
21

52%
48%
100%

52%
48%
100%

52%
100%

Valid

Valid

Valid

* Pharm = pharmaceutical program, OP = outpatient program, Res = residential program
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Table 7
Amount of Specialized Foster Parent Training (Foster Mothers).
Foster Mothers
n
%
61%
14
30%
7
9%
2

Amount of Specialized Training
None
5 Hours or Less
13-24 Hours

Table 8
Satisfaction with Support Received from Friends.
Biological Mothers
Level of Satisfaction
n
%
Very Dissatisfied
3
14%
Moderately Dissatisfied
1
5%
Slightly Dissatisfied
1
5%
Neither
2
10%
Slightly Satisfied
7
33%
Moderately Satisfied
3
14%
Very Satisfied
4
19%

Foster Mothers
n
%
0
0%
0
0%
3
12%
1
4%
8
31%
4
15%
10
39%

Total Sample
N
%
3
6%
1
2%
4
9%
3
6%
15
32%
7
15%
14
30%

Table 9
Total Karitane Parenting Confidence Scale (KPCS) Scores.

Total KPCS Score

Biological Mothers
Mdn Min Max
42 35
45
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Foster Mothers
Mdn Min Max
42 35
45

Total Sample
Mdn Min Max
42
35
45

Table 10
Responses to Items on the Karitane Parenting Confidence Scale (KPCS).

KPCS Item
Item 1

Response on KPCS
N/A
No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

Biological
Foster
Total
Mothers
Mothers
Sample
n
%
n
%
N
%
0
0% 0
0% 0
0%
1
5% 0
0% 1
2%
0
0% 0
0% 0
0%
0
0% 0
0% 0
0%
20
95% 28
100% 48
98%

Item 2

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
1
20

0% 0
0% 0
5% 3
95% 25

0% 0
0% 0
11% 4
89% 45

0%
0%
8%
92%

Item 3

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
4
17

0% 0
0% 0
19% 2
81% 26

0% 0
0% 0
7% 6
93% 43

0%
0%
12%
88%

Item 4

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
2
19

0% 0
0% 0
10% 2
96% 26

0% 0
0% 0
7% 4
93% 45

0%
0%
8%
92%

Item 5

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
3
18

0% 0
0% 0
14% 7
86% 21

0% 0
0% 0
25% 10
75% 39

0%
0%
20%
80%

Item 6

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
1
20

0% 0
0% 0
5% 5
95% 23

0% 0
0% 0
18% 6
82% 43

0%
0%
12%
88%

Item 7

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
0
21

0% 0
0% 0
0% 2
100% 26

0% 0
0% 0
7% 2
93% 47

0%
0%
4%
96%
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Item 8

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
4
17

0% 0
0% 0
19% 7
81% 21

0% 0
0% 0
25% 11
75% 38

0%
0%
22%
78%

Item 9

N/A
No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

3
1
2
3
12

14% 4
5% 0
10% 1
14% 2
57% 21

14% 7
0% 1
4% 3
7% 5
75% 33

14%
2%
6%
10%
67%

Item 10

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
1
20

0% 0
0% 0
5% 2
95% 26

0% 0
0% 0
7% 3
93% 46

0%
0%
6%
94%

Item 11

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
0
21

0% 0
0% 0
0% 1
100% 27

0% 0
0% 0
4% 1
96% 48

0%
0%
2%
98%

Item 12

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

2
4
13
1

10% 7
20% 11
65% 10
5% 0

25% 9
39% 15
36% 23
0% 1

19%
31%
48%
2%

Item 13

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
6
14

0% 0
0% 0
30% 7
70% 21

0% 0
0% 0
26% 13
75% 35

0%
0%
27%
73%

Item 14

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

0
0
3
17

0% 0
0% 0
15% 4
85% 24

0% 0
0% 0
14% 7
86% 41

0%
0%
15%
85%

Item 15

No, hardly ever
No, not very often
Yes, some of the time
Yes, most of the time

1
0
6
14

5% 0
0% 0
29% 9
67% 19

0% 1
0% 0
32% 15
68% 33

2%
0%
31%
67%
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Table 11
Demographics: Biological Mothers vs. Foster Mothers (Ranks).
Ranks
Mean Rank

n
Age

Negative Ranks
Positive Ranks
Ties
Total

Marital Status

Educational Level

8.05

88.50

3

5.50

16.50

Negative Ranks

14d

8.36

117.00

Positive Ranks
Ties
Total

1
3
18

3.00

3.00

Negative Ranks

10g

9.65

96.50

5

4.70

23.50

Ties
Total

3
18

Negative Ranks

10j

8.75

87.50

5

6.50

32.50

15m

10.70

160.50

3

3.50

10.50

Positive Ranks
Ties
Total
Household Income

11a
4
18

Positive Ranks

Employment Status

Sum of Ranks

3
18

Negative Ranks
Positive Ranks
Ties
Total

0
18

a. Age (biological mothers) < Age (foster mothers); d. Marital Status (biological mothers) < Marital Status
(foster mothers); g. Educational Level (biological mothers) < Educational Level (foster mothers); j.
Employment Status (biological mothers) < Employment Status (foster mothers); m. Household Income
(biological mothers) < Household Income (foster mothers)
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Table 12
Demographics: Biological Mothers vs. Foster Mothers (Statistics).
Test Statisticsa
Z
-2.30b

Age

p
0.02

Marital Status

-3.32

b

0.001

Educational Level

-2.11b

0.04

Employment Status

-1.61b

0.11

b

0.001

Household Income

-3.29

a. Wilcoxon Signed Ranks Test
b. Based on positive ranks.

Table 13
KPCS Scores for Biological Mothers in Past vs. Current Treatment (Ranks).

Group
Current Pregnancy
Past Pregnancy
Total

KPCS Score

Ranks
n
Mean Rank
9
9.11
11
11.64
20

Sum of Ranks
82.00
128.00

Table 14
KPCS Scores for Biological Mothers in Past vs. Current Treatment (Statistics).
Test Statisticsa
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)

KPCS Score
37.00
82.00
-0.98
0.33
0.37b

Exact Sig. [2*(1-tailed Sig.)]
a. Grouping Variable: group
b. Not corrected for ties.
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Table 15
KPCS Scores for Foster Mothers With vs. Without Training (Ranks).

KPCS Score

Ranks
Group
n
Mean Rank
Foster Mothers with Training
9
9.44
Foster Mothers without Training 14
13.65
Total
23

Table 16
KPCS Scores for Foster Mothers With vs. Without Training (Statistics).
Test Statisticsa
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]

KPCS Score
40.00
85.00
-1.46
0.14
0.16b

a. Grouping Variable: FM_group
b. Not corrected for ties.
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Sum of Ranks
85.00
191.00

CHAPTER 4
DISCUSSION
Findings
Given the rising number of infants being born who were prenatally exposed to
opioids (Ko et al., 2016), gaining a better understanding of this at-risk population and
their caregivers is essential to providing family-centered care that facilitates resiliency
and optimal child outcomes. This study sought to identify potential demographic risk and
protective factors for biological mothers and foster mothers caring for infants who were
exposed to opioids in utero. It also sought to determine whether prenatal treatment
programs for biological mothers who used or were treated with opioids during pregnancy,
and specialized training for foster mothers, would be associated with changes in PSE.
Results from the current study discovered a significant difference in the
demographic representation between the biological mother and foster mother samples.
On average, biological mothers were younger, more likely to be single mothers, and
reported lower levels of education and household income. Results did not find that PSE
was higher for biological mothers who participated in treatment programs during their
current pregnancy compared to biological mothers who participated in treatment
programs during a past pregnancy. It also did not find that PSE was higher for foster
mothers who received more than five hours of specialized training relating to prenatal
drug exposure compared to foster mothers who did not receive specialized training in the
previous 12 months. Overall, both samples of biological mothers and foster mothers
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reported relatively high PSE per their responses on the KPCS, regardless of the type of
treatment program accessed or the hours of specialized training received.
The significant differences in demographic characteristics discovered between the
samples of biological mothers and foster mothers adds to the existing literature by
providing additional insight into demographic risk and protective factors in families
caring for this population of infants. The finding that biological mothers were younger,
more likely to be single mothers, and reported lower levels of education and income than
foster mothers is consistent with previous research studying maternal substance use
(Haabrekke, Siqveland, Smith, Wentzel-Larsen, & Walhovd, 2015). As previous research
has also shown, these characteristics are linked to environmental risk factors that may be
associated with poor developmental outcomes, from physical and mental health to
cognitive development and language processing skills (Bradley & Corwyn, 2002;
Fernald, Marchman, & Weisleder, 2013).
Along with these risk factors, however, protective factors were also identified,
which can help facilitate family resilience (Benzies & Mychasiuk, 2009) in this
population. Per Benzies and Mychasiuk (2009), family resilience is the ability of a family
to use protective factors to cope with adversity. While risk factors increase the likelihood
of poor outcomes, protective factors act as buffers to adversity and can mitigate negative
outcomes (Benzies & Mychasiuk, 2009). Within both samples of mothers, higher PSE
scores might indicate more positive parenting practices that can alleviate potential effects
of the risk factors mentioned previously (Serbin & Karp, 2004). For foster mothers, more
adequate household income and better social support can also be a protective factor for
development (Benzies & Mychasiuk, 2009). Finally, in both samples, mothers were
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actively engaged in healthcare programs targeting their health as well as the health of
their child, which presents another protective factor as the use of available healthcare
services can increase family resiliency (Simon, Murphy, & Smith, 2005).
The current study is the first to the researchers’ knowledge to examine
associations between PSE and treatment programs accessed by biological mothers or
specialized training accessed by foster mothers caring for infants who were prenatally
exposed to opioids. While a significant association between PSE and participation in
treatment programs or training was not found, this should not be taken to indicate that
these interventions are ineffective at influencing PSE in this population. The lack of an
association, instead, serves to illustrates the multifaceted, dynamic nature of self-efficacy,
which can be influenced by many internal and external variables (Bandura, 2012), and
sheds light on how PSE is self-reported among this population of women.
Bandura (1982) notes that discrepancies in self-efficacy can occur due to deficient
self-knowledge, misjudgment of task requirements, and new experiences that can lead to
a reassessment of one’s self-efficacy, among other factors. Self-efficacy can also differ
between individuals based on the activity domain itself, as well as specific aspects of the
given activity (Bandura, 2012). In the current study, nearly a quarter of biological
mothers in the sample were first-time mothers who might have reported higher PSE due
to lacking previous personal or vicarious experiences that would enable them to rate their
own parenting performance accurately. Alternatively, mothers with one or more previous
children, which included the majority of the foster mothers in the sample, might report
higher PSE due to already possessing that experiential knowledge.
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Previous studies have also examined ways in which a parent’s perception of their
child’s behavior has the potential to influence PSE (Pierce et al., 2010). In a longitudinal
study of 1,836 mothers, Pierce et al. (2010) found that despite the increased adoption of
hostile-reactive parenting (HRP) in toddlerhood, there was little change in PSE. The
authors suggest that although performance is tied to self-efficacy, PSE might have been
resistant to increasing HRP as mothers attributed negative outcomes to external factors,
such as difficult child temperament, rather than parenting performance (Pierce et al.,
2010). Given the myriad of symptoms associated with prenatal substance exposure
(Kocherlakota, 2014), it is possible that mothers in the current study rated their PSE more
highly because they attributed challenges in care to the infant’s symptoms or behaviors,
and not their skills as mothers.
In addition to consideration of these factors, these findings contribute to the
current PSE literature, which presents inconsistent findings related to of PSE among
caregivers of medically complex infants and children. For example, in a study of mothers
of children with autism spectrum disorder (ASD), mothers reported significantly lower
self-efficacy about parenting their child with ASD than about their typically developing
child (Meirsschaut et al., 2010). In another study by Porter and Hsu (2003), self-efficacy
was significantly reduced in mothers of infants who were prone to distress and difficult to
soothe, which can often be true of infants with a history of prenatal substance exposure
(Boukydis & Lester, 2008). However, another study found no significant difference in
PSE between parents of very preterm infants compared to parents of preterm and term
infants (Pennell, Whittingham, Boyd, Sanders, & Colditz, 2012). Additionally, in a
longitudinal study of 25 mothers of children with Down syndrome, researchers found that
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while maternal satisfaction with parenting increased as children grew older, levels of PSE
did not change and were similar to mothers of typically developing children (Gilmore &
Cuskelly, 2012). These studies examined different populations of infants and children, of
course, but it could be assumed that similarities exist in the additional demands and
stressors placed on parents of these children when compared to parents of typically
developing children.
The difference in level of satisfaction with support received from friends between
biological mothers and foster mothers is also important to note. Previous research has
suggested that social support can act as a predictor of higher PSE. Teti and Gelfand
(1991) found that PSE correlated with social-marital supports, while Kersh et al. (2006)
discovered that while marital quality predicted PSE for mothers, external social support
predicted PSE for fathers. In addition to being associated with higher self-efficacy, better
social support may also predict improved mental well-being in first-time mothers (Ginja,
Coad, Bailey, Kendall, & Goodenough, 2018). In the current study, however, the
differences in social satisfaction did not influence PSE.
In addition, about half of all participating mothers indicated that being a mother is
very stressful some or most of the time per their response to item 22 in the KPCS,
including 70% of biological mothers and 30% of foster mothers. However, the perceived
stress related to being a mother was not associated with changes in PSE. This is in
contrast to previous general parenting research, which has found that increased PSE may
be related to decreased stress and that higher levels of PSE may mediate adverse effects
of parenting stress in certain populations, including parents of premature children and
children with ASD (Kwok & Wong, 2000; Weiss et al., 2013; Woods, 2011). Despite the
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lack of an association between these variables in the current study, it is worth noting the
difference in perceived stress between the two samples, with more biological mothers in
the sample reporting that being a mother is very stressful compared to foster mothers.
Limitations
There are several limitations to consider when interpreting the results of this
study. First, the study had a small sample size of participating biological mothers and
foster mothers, and it did not include a control group of mothers caring for infants who
were not prenatally exposed to opioids. The study also relied upon self-report, in which
parenting constructs may be particularly vulnerable to distortion, and measurement error
and conscious bias may occur more often compared to records or behavioral observation
measures (Morsbach & Prinz, 2006). Further, several eligible mothers declined to take
the survey, potentially indicating that mothers who chose to participate were more
confident in their parenting skills. It is also possible that some mothers who used
substances during their pregnancy declined to take the survey due to fear of losing
custody of their child, fear of punishment by treatment providers and social services, and
stigmatization around substance use (Bush, 2005; Kahn et al., 2017). Finally, all
participants lived within or near the Louisville metropolitan area; therefore, responses are
representative only of a single geographic region with relatively greater access to
programs when compared to rural communities.
Clinical Implications
This study presents potential demographic risk and protective factors that should
be taken into consideration by healthcare providers when developing intervention plans
for children who have a history of prenatal substance exposure. Further, given the
tendency of biological mothers and foster mothers to report high PSE in the current
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study, regardless of treatment programs or training accessed, alternative approaches to
parental education and counseling may be beneficial when providing care to children
with a history of prenatal substance exposure. For example, mothers could benefit from
additional guidance or training to accurately self-evaluate skills needed for effective
carryover of a home exercise program. Education that integrates multiple channels for
increasing self-efficacy, as proposed by Bandura (1982), might be beneficial. In addition
to asking mothers to practice a skill (enactive mastery), mothers could benefit from
observing and analyzing models of the skills (vicarious experience), receiving verbal
feedback from the therapist (verbal/social persuasion), and identifying ways to reduce
stress related to parenting (emotional/physiological arousal). Mindfulness-based
parenting interventions could also be of benefit given the high percentage of mothers in
this study reporting that being a mother is stressful. Adding mindfulness parenting to
treatment programs for mothers using substances has been proven effective at reducing
stress within this at-risk population (Short et al., 2017). Strategies such as mindfulness
training might also help caregivers increase self-awareness and reflect more accurately on
complex situations (Benn, Akiva, Arel, & Roeser, 2012).
Future Directions
Future research can continue to contribute to an informed understanding of this
growing population of infants and children, and their caregivers. It can clarify the specific
support needs to increase resiliency, optimize early experiences, and improve the childrearing environment, thereby maximizing long-term developmental outcomes. The
current study focused only on mothers, but other family members are increasingly
involved in the care of these infants and children, including fathers, grandparents, aunts,
and uncles. Future research could include the unique perspectives of this diverse group of
39

caregivers. A research study based on focus group interaction with caregivers is an
alternate model that could provide rich qualitative data. As the current study examined
associations with PSE at one point in time, additional research might examine levels of
PSE before and after an intervention, such as a treatment program geared toward mothers
using substances or a specialized training program for foster parents. Future studies might
also examine differences in PSE at specific intervals during a child’s development.
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APPENDIX: ABBREVIATIONS
ACE

Adverse childhood experience

BEIP

Bucharest Early Intervention Project

BSID-II

Bayley Scales of Infant Development-II

CBH

Center for Behavioral Health

EEG

Electroencephalography

HRP

Hostile reactive parenting

IRB

Institutional Review Boards

KPCS

Karitane Parenting Confidence Scale

MAT

Medication assisted treatment

MAW

Medication assisted withdrawal

NAS

Neonatal abstinence syndrome

NCN

Norton Children’s Neonatology

NOWS

Neonatal opioid withdrawal syndrome

MSE

Maternal self-efficacy

PPSE

Perceived parental self-efficacy

PSE

Parental self-efficacy

RFI

Relationship-focused intervention

RO

Research Office

SIT

Standard integrated treatment

SUD

Substance use disorders
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WHO

World Health Organization

WHOQOL

World Health Organization Quality of Life

WPPSI

Wechsler Preschool Primary Test of Intelligence
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